Lovastatin; Simvastatin Imp. E (EP); Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester, [1S-[1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta]]-; (+)-Mevinolin; 6alpha-Methylcompactin; Altocor; Altoprev; Antibiotic MB 530B; L 154803; Lestric; Lostatin; Lovacard; Lovalip; Lovastatin lactone; Lovex; MK 803; MSD 803; Mevacor; Mevinacor; Mevinolin; Mevlor; Monacolin K; Monacolin K lactone; NSC 633781; Sivlor; Simvastatin Impurity E

名称与同义词

• lovastatin
• mevinolin
• Mevacor
• Monacolin K
• Mevinacor
• Altoprev
• Mevlor
• Sivlor
• Altocor
• Lovalip
• 75330-75-5
• Lovastatine
• Lovalord
• Nergadan
• Artein
• Hipovastin
• Lovastatina
• Lovasterol
• Cholestra
• Closterol
• Teroltrat
• Lestatin
• Lipofren
• Lovastin
• Tecnolip
• Colevix
• Hipolip
• Lipivas
• Lozutin
• Paschol
• Rodatin
• Rovacor
• Belvas
• Lipdip
• Taucor
• Lovastatinum
• 6alpha-Methylcompactin
• 6-Methylcompactin
• Lovastatine [French]
• Lovastatinum [Latin]
• Liposcler
• Rextat
• Lovastatina [Spanish]
• 6 Methylcompactin
• 6-alpha-Methylcompactin
• lostatin
• Monakolin K
• Advicor
• Tancor
• MK-803
• Mevinacor;
• Lipofren;
• Nergadan;
• (+)-mevinolin
• Mevacor;
• Lovastatin CRS
• lovastatin lactone
• Mevacor (TN)
• Monacolin K;
• 1cqp
• Lovastatin [USAN]
• Mevinacor 10
• Mevinacor 40
• 6 alpha-Methylcompactin
• Altoprev (TN)
• Statosan (TN)
• Lovastatin & Primycin
• Lovastatin (Standard)
• Monacolin K lactone
• Prestwick_819
• Advicor (TN)
• Altocor (TN)
• Lovastatin =97%
• 9LHU78OQFD
• Lovastatin, 1 alpha
• Lovastatin (Mevacor)
• Lovastatinum (Latin)
• Lovastatin (USP/INN)
• 6.alpha.-Methylcompactin
• Mevinolin (lovastatin)
• UNII-9LHU78OQFD
• Antibiotic MB-530B
• Lovastatin (Mevinolin)
• RefChem:5964
• 1 alpha-Isomer Lovastatin
• MSD 803
• Simvastatin EP Impurity E
• LOVASTATIN [MI]
• Lovastatin, 97% 5g
• DTXSID5020784
• Lovastatin [USAN:BAN:INN]
• MK 803
• alpha-Isomer Lovastatin, 1
• LOVASTATIN [INN]
• Opera_ID_1578
• Prestwick0_000516
• Prestwick1_000516
• Prestwick2_000516
• Prestwick3_000516
• Spectrum3_001873
• Spectrum5_001294
• Lovastatin (MK-803)
• LOVASTATIN [HSDB]
• MLS000069585
• LOVASTATIN [VANDF]
• CHEMBL503
• D06WTZ
• DTXCID50784
• C24H36O5
• HSDB 6534
• AC1L1EI6
• AC1Q2C7T
• C10AA02
• LOVASTATIN [MART.]
• Mevinolin from Aspergillus sp.
• SCHEMBL3136
• CCRIS 8092
• Lovastatin, 1 alpha Isomer
• Lovastatin, 1 alpha-Isomer
• PCZOHLXUXFIOCF-BXMDZJJMSA-N
• LOVASTATIN [USP-RS]
• LOVASTATIN [WHO-DD]
• MK803
• US9115116, lovastatin
• BIDD:PXR0113
• MFCD00072164
• Sigma 1370600
• BSPBio_000471
• BSPBio_001265
• BSPBio_003346
• CHEBI:40303
• cid_53232
• KSC377A8D
• MLS001055358
• MLS006011867
• US9353061, Lovastatina
• ARONIS24208
• BIDD:GT0749
• DivK1c_001032
• Lovastatin [USAN:INN:BAN]
• NSC-758662
• SPECTRUM1503977
• ML-530B
• SPBio_002392
• BPBio1_000519
• GTPL2739
• Lovastatin - Bio-X trade mark
• Lovastatin [USAN:USP:INN:BAN]
• MEGxm0_000398
• orb1309414
• LOVASTATIN [ORANGE BOOK]
• ACon0_000534
• ACon1_000390
• BDBM34168
• CTK2H7081
• ERK5-3O05
• HMS503O05
• HY-N0504R
• KBio1_001032
• KBio3_002848
• LOVASTATIN, 97% 5G.
• AOB5269
• BRN 3631989
• LOVASTATIN [EP MONOGRAPH]
• Lovastatin, (1 alpha(S*))-Isomer
• MB-530B
• MSD-803
• Simvastatin impurity, lovastatin-
• Lovastatin for peak identification
• NINDS_001032
• NSC633781
• GLXC-06458
• HMS1569H13
• HMS1792O07
• HMS1923O13
• HMS1990O07
• HMS2089M06
• HMS2093O03
• HMS2096H13
• HMS2236F07
• HMS3039N16
• HMS3259F10
• HMS3268C03
• HMS3403O07
• HMS3412H19
• HMS3676H19
• HMS3713H13
• HMS3884B03
• LOVASTATIN [USP MONOGRAPH]
• LOVASTATIN, 97% 25G.
• Pharmakon1600-01503977
• SMR000058779
• ADVICOR COMPONENT LOVASTATIN
• ACT02620
• ALBB-027272
• CID53232
• HY-N0504
• MK-803; LOVALIP; MEVACOR
• MSK10235
• ZINC3812841
• LOVASTATIN (REFERENCE GRADE)
• Tox21_110888
• Tox21_201475
• Tox21_300268
• ANW-41686
• BBL024473
• CCG-39627
• CID:53232
• EBC-02080
• L-154803
• NCGC00023509-03
• NSC758662
• NSC779704
• s2061
• SBB080686
• STK801953
• AKOS005267139
• Lovastatin for peak identification CRS
• Lovastatin; Simvastatin EP Impurity E
• Tox21_110888_1
• ACN-057049
• C24-H36-O5
• CS-1990
• CS-O-05971
• DB00227
• EBD2126857
• FH24950
• KS-1082
• Lovastatin, 97% - 100MG 100mg
• Mevinolin from Aspergillus sp., powder
• NC00713
• NSC 758662
• NSC-633781
• NSC-779704
• RTR-031803
• IDI1_001032
• NCGC00023509-04
• NCGC00023509-05
• NCGC00023509-06
• NCGC00023509-07
• NCGC00023509-08
• NCGC00023509-09
• NCGC00023509-10
• NCGC00023509-11
• NCGC00023509-13
• NCGC00023509-14
• NCGC00023509-16
• NCGC00254157-01
• NCGC00259026-01
• AC-13961
• BL164644
• butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
• CJ-10768
• CPD000673570
• G226
• J22.276C
• LS-46359
• SAM002589904
• SAM002589963
• SC-11968
• SID:53789068
• SMR000673570
• EC 616-212-7
• SBI-0051881.P002
• AB0108514
• CAS-75330-75-5
• 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
• A4365
• CS-0694830
• FT-0627986
• FT-0658728
• FT-0776781
• H0143
• L0214
• N1632
• NS00000544
• SIMVASTATIN IMPURITY E [EP IMPURITY]
• (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
• EN300-52515
• C07074
• D00359
• J10136
• M02056
• S-7779
• [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
• 28048-EP2269989A1
• 28048-EP2270011A1
• 28048-EP2272825A2
• 28048-EP2272841A1
• 28048-EP2277507A1
• 28048-EP2277865A1
• 28048-EP2280006A1
• 28048-EP2281813A1
• 28048-EP2284158A1
• 28048-EP2286795A1
• 28048-EP2287165A2
• 28048-EP2287166A2
• 28048-EP2289892A1
• 28048-EP2292620A2
• 28048-EP2295406A1
• 28048-EP2295409A1
• 28048-EP2298742A1
• 28048-EP2298745A1
• 28048-EP2298772A1
• 28048-EP2298776A1
• 28048-EP2298779A1
• 28048-EP2301923A1
• 28048-EP2301931A1
• 28048-EP2301936A1
• 28048-EP2305648A1
• 28048-EP2308839A1
• 28048-EP2311808A1
• 28048-EP2311829A1
• 28048-EP2314588A1
• 96638-EP2287163A1
• 96638-EP2305678A1
• AB00052400-17
• AB00052400_18
• AB00052400_19
• Mevinolin from Aspergillus sp., >=98% (HPLC)
• 117141-EP2272825A2
• 117141-EP2298776A1
• 330L755
• A838030
• A838383
• D008148
• Q417740
• SR-01000000123
• SR-05000001880
• (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
• (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
• I06-1876
• SR-01000000123-3
• SR-05000001880-1
• SR-05000001880-2
• BRD-K09416995-001-06-8
• BRD-K09416995-001-21-7
• BRD-K09416995-001-38-1
• BRD-K09416995-001-39-9
• BRD-K09416995-001-40-7
• Lovastatin, 1 alpha-Isomer (without R*/S* notation)
• Mevacor;Monacolin K;mevinolin;6-alpha-Methylcompactin
• (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
• (S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
• (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
• 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone
• Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-
• SIMVASTATIN IMPURITY, LOVASTATIN- [USP IMPURITY]
• Z754931258
• 74133-25-8
• Lovastatin, 98%, an inhibitor of HMG-CoA reductase - 1G 1g
• (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
• (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate
• [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
• Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-
• ((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2R)-2-methylbutanoate
• ((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate
• (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat
• (2R)-2alpha,6beta-Dimethyl-2,3,4,4abeta,5,6-hexahydro-4alpha-[[(2S)-2-methylbutyryl]oxy]-5beta-[2-[(2R)-4beta-hydroxy-6-oxotetrahydro-2H-pyran-2alpha-yl]ethyl]naphthalene
• (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl-2-methyl butanoate
• (2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER
• (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
• (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene-1-yl ester
• (2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester
• (2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl Ester
• (2S)-2-Methylbutyric acid (1S)-1,2,3,7,8,8aalpha-hexahydro-3beta,7alpha-dimethyl-8alpha-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]naphthalen-1beta-yl ester
• (3R,5R)-3,5-Dihydroxy-7-[(1S)-2beta,6alpha-dimethyl-8alpha-[[(S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8abeta-hexahydronaphthalene-1beta-yl]heptanoic acid 1,5-lactone
• (8-(2-(4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate
• (S)-((1S,3R,7S,8S,8AR)-8-(2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-2H-PYRAN-2-YL)ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL) 2-METHYLBUTANOATE
• (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester
• (S)-2-Methylbutanoic acid (1S)-1,2,3,7,8,8aalpha-hexahydro-3beta,7alpha-dimethyl-8alpha-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]naphthalen-1beta-yl ester
• (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one
• [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
• 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate
• 1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
• 616-212-7
• 8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl (2S)-2-methylbutanoate
• 8-[2-(4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthale
• 8-[2-(4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl 2-methylbutanoate
• Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-
• Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-
• Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta,8-beta-(2S*,4S*),8a-beta))-
• BUTANOIC ACID, 2-METHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.(R*),3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8.ALPHA..BETA.))-
• Butanoic acid, 2-methyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester,(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))
• Lovastatin; Simvastatin Imp. E (EP); Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester, [1S-[1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta]]-; (+)-Mevinolin; 6alpha-Methylcompactin; Altocor; Altoprev; Antibiotic MB 530B; L 154803; Lestric; Lostatin; Lovacard; Lovalip; Lovastatin lactone; Lovex; MK 803; MSD 803; Mevacor; Mevinacor; Mevinolin; Mevlor; Monacolin K; Monacolin K lactone; NSC 633781; Sivlor; Simvastatin Impurity E